G & PHarma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
G & PHarma
Largest movements
- Receivables within one year -€15,053
down €15,053 (-31.2%), from €48,322 to €33,269
of which Trade receivables: -€25,367
- Current portion of long-term debt -€63,931
down €63,931 (-89.7%), from €71,307 to €7,376
- Reserves +€27,997
up €27,997 (+7.5%), from €375,420 to €403,418
of which Distributable reserves: +€27,997
- Accrued charges and deferred income +€14,813
up €14,813 (+60.0%), from €24,689 to €39,502
- Staff costs +€27,658
up €27,658 (+24.0%), from €115,300 to €142,959
- Financial charges +€15,382
up €15,382 (+59.0%), from €26,051 to €41,434
- Taxes -€12,975
down €12,975 (-52.1%), from €24,882 to €11,907
- Depreciation +€2,797
up €2,797 (+70.5%), from €3,964 to €6,761
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,144,675 | €1,126,981 | -€17,694 | -1.5% |
| Fixed assets | 21/28 | €1,091,797 | €1,085,036 | -€6,761 | -0.6% |
| Tangible fixed assets | 22/27 | €29,702 | €22,941 | -€6,761 | -22.8% |
| Furniture and vehicles | 24 | €29,702 | €22,941 | -€6,761 | -22.8% |
| Financial fixed assets | 28 | €1,062,094 | €1,062,094 | = | 0.0% |
| Current assets | 29/58 | €52,878 | €41,945 | -€10,933 | -20.7% |
| Amounts receivable within one year | 40/41 | €48,322 | €33,269 | -€15,053 | -31.2% |
| Trade receivables | 40 | €25,367 | €0 | -€25,367 | -100.0% |
| Other amounts receivable | 41 | €22,955 | €33,269 | +€10,314 | +44.9% |
| Cash at bank and in hand | 54/58 | €1,215 | €5,622 | +€4,407 | +362.8% |
| Deferred charges and accrued income | 490/1 | €3,342 | €3,055 | -€286 | -8.6% |
| Total equity and liabilities | 10/49 | €1,144,675 | €1,126,981 | -€17,694 | -1.5% |
| Equity | 10/15 | €489,420 | €517,418 | +€27,997 | +5.7% |
| Contributions | 10/11 | €114,000 | €114,000 | = | 0.0% |
| Reserves | 13 | €375,420 | €403,418 | +€27,997 | +7.5% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €375,420 | €403,418 | +€27,997 | +7.5% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €655,255 | €609,563 | -€45,691 | -7.0% |
| Amounts payable after more than one year | 17 | €18,453 | €11,077 | -€7,376 | -40.0% |
| Financial debts | 170/4 | €18,453 | €11,077 | -€7,376 | -40.0% |
| Amounts payable within one year | 42/48 | €612,112 | €558,985 | -€53,128 | -8.7% |
| Current portion of amounts payable after more than one year | 42 | €71,307 | €7,376 | -€63,931 | -89.7% |
| Financial debts | 43 | €11,818 | €11,833 | +€14 | +0.1% |
| Credit institutions | 430/8 | €11,818 | €11,833 | +€14 | +0.1% |
| Trade debts | 44 | €2,734 | €3,284 | +€549 | +20.1% |
| Suppliers | 440/4 | €2,734 | €3,284 | +€549 | +20.1% |
| Taxes, remuneration and social security | 45 | €29,921 | €36,720 | +€6,799 | +22.7% |
| Taxes | 450/3 | €6,122 | €8,262 | +€2,140 | +35.0% |
| Remuneration and social security | 454/9 | €23,799 | €28,458 | +€4,659 | +19.6% |
| Other amounts payable | 47/48 | €496,331 | €499,772 | +€3,441 | +0.7% |
| Accrued charges and deferred income | 492/3 | €24,689 | €39,502 | +€14,813 | +60.0% |
| Non-recurring operating income | 76A | €3,306 | €0 | -€3,306 | -100.0% |
| Remuneration, social security and pensions | 62 | €115,300 | €142,959 | +€27,658 | +24.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,964 | €6,761 | +€2,797 | +70.5% |
| Other operating charges | 640/8 | €1,755 | €1,619 | -€137 | -7.8% |
| Gross operating margin | 9900 | €234,993 | €232,677 | -€2,316 | -1.0% |
| Operating profit (loss) | 9901 | €113,973 | €81,338 | -€32,635 | -28.6% |
| Financial income | 75/76B | €519 | €0 | -€519 | -100.0% |
| Recurring financial income | 75 | €519 | €0 | -€519 | -100.0% |
| Financial charges | 65/66B | €26,051 | €41,434 | +€15,382 | +59.0% |
| Recurring financial charges | 65 | €26,051 | €41,434 | +€15,382 | +59.0% |
| Profit (loss) for the period before taxes | 9903 | €88,441 | €39,904 | -€48,537 | -54.9% |
| Income taxes | 67/77 | €24,882 | €11,907 | -€12,975 | -52.1% |
| Profit (loss) for the period | 9904 | €63,559 | €27,997 | -€35,561 | -56.0% |
| Profit (loss) for the period to be appropriated | 9905 | €63,559 | €27,997 | -€35,561 | -56.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.